TruthArchive.ai - Related Video Feed

ADHD is a brain disorder causing distractibility, fidgeting, and impulsivity in both kids and adults. The brains of people with ADHD are smaller in some areas, especially the frontal lobe, impacting impulse control, concentration, and inhibition. Brain development is slower, and neural pathways don't connect and mature at the same rate, making it harder to pay attention and focus. This can impair executive function, which handles organization and routine tasks. People with ADHD may have problems processing dopamine, a chemical linked to movement, sleep, attention, and learning. ADHD can be tricky to diagnose and challenging to manage, but treatments can help.

Laura Delano discusses her experience with psychiatric drugs, starting at age 13. She claims the "chemical imbalance" theory is a lie and that 66 million Americans are on these drugs. She describes Post-SSRI Sexual Dysfunction (PSSD) and the outrage she faced after sharing her story of getting off medication. Delano recounts being diagnosed with bipolar disorder at 14 and put on a cocktail of drugs, including antidepressants, mood stabilizers, and antipsychotics. She says she was told it was a lifelong, incurable condition. She says there are no objective tests for mental illness, only subjective observations. She describes feeling numb and disconnected while on the drugs, and experiencing physical side effects like digestive issues and weight fluctuations. Delano says the drugs impaired her ability to think critically and connect with others. She says she eventually realized the treatment was making her sicker. She highlights the lack of long-term safety studies and the dangers of polypharmacy. She advocates for informed consent and questions the motives of the mental health industry. She emphasizes the importance of community, empathy, and finding purpose as alternatives to medication. She says she experienced withdrawal symptoms when she stopped taking the drugs. She says she found purpose in sharing her story and helping others make informed choices.

Depression is not caused by a deficiency in a serotonin reuptake inhibitor, but rather a general deficiency in serotonin. Serotonin is made in the gut through methylation, and 90% of the body's serotonin resides there. Therefore, if there isn't enough serotonin in the gut, there won't be enough elsewhere in the body. Depression usually begins in the gut, not as an outside cluster of symptoms.

Speaker 0 discusses the effectiveness and limits of psychiatric treatment. They say: “How many patients have you been able to cure so far? I would say one.” They also state, “There are no real cures right now in psychiatry. I don’t know that any of us are ever completely cured of anything.” On biological tests for mental illness, they remark, “What kind of biological tests do we have available today for detecting mental illnesses? None. I always felt like I was throwing darts in the dark at my patients and had hurt some of them.” They list various medications, including “Lithium. Remeron is another one. Trazodone. Zagradog. Depakure, levothyroxine. Amexico. Equatroids. Depakure. Lithium. Ambien. You may need an antidepressant also with a with pempectomy.” They warn about safety, noting that “There is a reason that most psychiatric medications have black box warnings. Give them to the wrong person, and you can precipitate a disaster.” They acknowledge uncertainty in efficacy: “We don't know if I give you a medication if it is going to work or not. To a certain degree, it's trial and error.” The speaker claims, “I have cured none of my patients.” Finally, they question who benefits: “The people who makes the diagnosis.”

"You're in the same." "If if, you're depressed, you're not deficient in a serotonin reuptake inhibitor, right?" "You you're deficient generally in serotonin." "And serotonin is made in the gut through this process called methylation." "90% of the serotonin in our bodies resides in our gut." "So if you don't have it here, you can't have it here." "Right." "So depression rarely begins in an outside cluster of symptoms." "It usually begins in the gut."

"Hypersexuality is associated with mania and ADD. It's also associated because porn is everywhere. And, you know, you can reset a child's template if they're exposed to sexuality too soon. It's often associated with people who have ADD or ADHD because the low dopamine availability in their brain, that's one of the reasons we think causes ADD, is being constantly sexual increases dopamine. Now, may wear out their pleasure centers, and then it takes more and more to get the same response. When people go through a manic episode, so clearly they become either hypersexual, hyper religious, spend money they don't have, I mean, very impulsive, they have pressured speech. But how you tell the difference between ADHD and bipolar disorder for people who have ADD or ADHD, it's sort of that way all the time. People who have bipolar disorder goes in clear cycles where they're just normal, fine one moment, maybe even depressed, and then boom, their brain cycles into a hypersexual or manic state."

Most ADHDers tend to prefer organizing things in buckets. In a bathroom closet example, many describe open storage with general themes for each bucket; within each bucket, it's a mess but sorted by categories. For to-do lists, they prefer buckets like categories such as home, work, personal, with lists that aren't hyper organized. The theory is a Goldilocks thing for us: another way to organize it could be to just have one giant long list, or if we're talking about the closet, to have one big bucket with everything mixed together. On physical items, we might not feel like putting red nail polish back with the other reds in the very specific order. When you know the way your brain prefers things to be organized, you can make systems around that. The link for the information is in my profile.

Lack of vitamins, particularly Vitamin B, can contribute to depression. Some psychiatrists are using high doses of vitamin B3 (nicotinic acid) to treat mental illness. A DVD called "Food Matters" highlights the importance of nutrition in health, sharing a story of a girl who recovered from a catatonic state after taking high doses of nicotinic acid. Lack of progesterone can also lead to depression, especially in women who have been exposed to chemicals or plastics. Balancing hormones and implementing the 8 laws of health can help ease off antidepressants. Excess pain, food, and stimulation can also contribute to chemical imbalances in the brain and should be addressed.

Dr. Josef Duhring and Dr. Yosef (Doctor Yosef Duhring) discuss antidepressants and SSRIs, outlining perceived risks, data limitations, and long-term concerns, followed by practical guidance on tapering and contact information for a tapering clinic. Key side effects and risks cited - Common side effects: gastrointestinal issues (nausea, vomiting, diarrhea), changes in sleep (insomnia or drowsiness), headaches, nervousness, restlessness, dry mouth, sweating, tremors, sexual dysfunction, decreased libido, difficulty reaching orgasm, erectile dysfunction, appetite and weight changes (gain or loss). - Other reported effects: emotional blunting, feeling less like yourself, dizziness, balance issues (especially early in treatment), increased sweating, abnormal dreams. - Serious but rarer risks: suicidal thoughts or behaviors, particularly under age 25; serotonin syndrome (described as rare); heart rhythm changes at high doses with some SSRIs. - Behavioral effects: mania, psychosis, irritability, aggression; rare but potentially misdiagnosed as bipolar disorder; in some cases leading to escalation to lithium or antipsychotics. - Sleep and long-term effects: SSRI use diminishing sleep quality (less REM and deep sleep), resulting in fatigue and brain fog in long-term users. - Long-term data gaps: “there has never been a randomized control study that looked at them for over a year,” and “seventy percent of antidepressant users are on these drugs for two years or more.” Claims that there is no long-term data on sustained efficacy or safety beyond eight to twelve weeks. Efficacy and data concerns - Most drugs reach market based on eight-week studies; there is a reported two-point difference on a 52-point depression scale between the drug and placebo, which is described as clinically very low. - Outcomes most meaningful to patients (employment, relationships, life meaning) are not directly measured in standard trials, which focus on scale-based movement. - The claim is made that long-term efficacy remains unproven and that the long-term data are unavailable. Observations about prescription patterns and systemic factors - Online “pill mill” platforms allegedly enable easy access to SSRIs (Lexapro), sometimes without video chats, via online questionnaires, with rapid mail delivery. - The dose of prescription and patient interactions are affected by time constraints and economic incentives in healthcare delivery, leading to faster checklists and medication-based treatments rather than in-depth discussions of life context, relationships, or non-drug approaches. - An “unholy alliance” between the pharmaceutical industry and academic medicine is described: investigators may pursue drug trials for career advancement and publications funded by drug companies, potentially biasing conclusions in favor of medications. - The FDA’s stance is portrayed as influenced by this environment, with concerns about regulatory capture and inadequate critical evaluation of risks, including suicide risk data and withdrawal issues. Key long-term and withdrawal considerations - Long-term withdrawal: physicians are described as telling patients that antidepressant withdrawal is mild and resolves in two weeks, but tapering often requires one to two years to avoid withdrawal symptoms; many are tapered too quickly, leading to relapse or withdrawal challenges. - Tapers and recovery: the clinician reports patients improving emotionally during tapering, sometimes even before complete discontinuation; success depends on broader life health improvements (physical health, relationships, purpose) and careful, gradual reduction. Three major concerns observed with antidepressants (as described by Dr. Yosef) - They don’t work for many patients in the long term; diminished efficacy over time due to emotional blunting and neurochemical adaptation. - Behavioral and cognitive changes: potential for mania, psychosis, irritability, and misdiagnosis as bipolar disorder; risk of “drug-induced” psychiatric symptoms. - Toxicity and sleep: long-term blunting reduces emotional responsiveness; chronic sleep disruption and brain fog; long-term toxicity may underlie persistent symptoms after prolonged use. Clinical implications and guidance offered - For those considering antidepressants, emotions matter and should be explored beyond a chemical-imbalance narrative; discuss physical health, relationships, purpose, substances, and non-drug approaches (therapy, lifestyle changes) before relying on medication. - For those already on SSRIs, a careful, patient-guided taper is advised: slowly reduce dosages, use approaches such as liquid tapering to control precise reductions, and listen to one’s body to avoid withdrawal; a two-year taper may be necessary for many patients. - Coming off antidepressants can reveal or restore aspects of life and personality; benefits may appear during tapering as engagement and motivation return, but life circumstances must be addressed in parallel to avoid relapse. Contact information - Tapering clinic website: taperclinic.com (for patients in the U.S.; clinic claims to operate in about 15–16 states, covering roughly 70% of the population). - YouTube channel for further resources: Doctor Yosef (German version) with a free drug tapering training (about five hours) and guidance for working with a doctor. Speaker names - Dr. Yosef Duhring (referred to as Doctor Josef Duhring in the discussion) and Dr. Yosef (the same speaker) are cited; their experiences include FDA and industry roles and a tapering clinic specializing in antidepressant withdrawal and discontinuation.

The speaker discusses a key tension in neuropharmacology related to dopamine’s roles. Dopamine is involved in movement and reward, and antipsychotic drugs used by schizophrenics block dopamine. The speaker notes that visible motor side effects, such as Cardibe Dyskinesia, emerge because those neuroleptic drugs reduce dopamine not only in the targeted regions but also in the spinal/motor system. The central problem highlighted is that most pharmaceuticals have side effects because chemicals like dopamine, serotonin, and acetylcholine operate in multiple brain regions, not solely where the intended repair is needed. The speaker clarifies a nuanced stance on industry: not strongly anti-big pharma, but very supportive of self-directed healthcare. This stance informs a practical initiative tied to the podcast: encouraging people to optimize daily routines to support mental health. The recommended practices include getting sunlight in the eyes in the morning and also in the evening, staying hydrated, exercising, and maintaining a normal circadian rhythm. The overarching idea emphasized is that one of the most important factors for mental health is bright mornings and days with dark nights, reinforcing the importance of light exposure patterns for well-being. In sum, the speaker links dopamine’s broad involvement to the side effects seen with neuroleptic treatments, underscoring that drugs affecting dopamine can impact movement and motor function while alleviating certain psychiatric symptoms. This leads to a broader view that while pharmaceutical interventions have limitations and side effects due to the widespread action of neurochemicals in the brain, empowering individuals through self-directed health measures—especially light exposure timing, hydration, exercise, and circadian regulation—can play a vital role in mental health alongside medical treatments.

"If you look at kids if you look at patients with anxiety, okay, and you because ADHD, anxiety, similar, pattern in the microbiome anyways. So if you look at patients with anxiety, and now I'm taking my anxious patient, and I see a signature microbiome. Some microbes are overgrown, some microbes are low, and what I'm gonna do is I'm basically gonna give that patient a drug. That drug is blunting here the anxiety. Right?" "But it doesn't fix the microbiome." "You have a signature microbiome for anxiety." "Well, the drugs are great because they're working up here." "They're not working at the gut level. So this the anxiety problem is still there." "Do you think people who have ADHD don't have ADHD and they actually just have anxiety?" "I think people with ADHD are lacking microbes. That's what I think." "And the medication doesn't help at all?" "I I think it probably cuts down the symptoms, but I don't think it fix The root." "which is the the business model of most drugs, by the way."

The main root cause of depression, anxiety, ADHD, and bipolar is metabolic dysfunction. Metabolism is biology, and when it's off, signs or symptoms of a problem are likely to appear in the brain or body. These can manifest as high blood pressure, high blood glucose leading to prediabetes or diabetes, obesity, or depression and anxiety.

Jacob's parents noticed behavioral issues when he turned three, and teachers suggested he was hyperactive. They resisted medicating him until he was diagnosed with ADHD and prescribed Ritalin. However, the medication caused anxiety, leading to more medications. At age nine, Jacob was diagnosed with a mood disorder and given multiple drugs. Eventually, his parents decided to strip him off all medication, but he was then diagnosed with bipolar disorder and put on lithium. Jacob experienced side effects and his parents felt doctors were experimenting with his treatment. The controversial diagnosis of childhood bipolar has seen a significant increase in recent years, but its validity and the use of medications in children remain uncertain.

Jacob's parents resisted medicating him for ADHD, but eventually gave in. The medication caused anxiety, leading to more medication and side effects. At age nine, Jacob was diagnosed with a mood disorder and given multiple medications. Feeling out of control, his parents decided to strip him off all medication. However, he was then diagnosed with bipolar disorder and prescribed lithium. The lack of therapeutic solutions and over-reliance on medication was frustrating. Jacob experienced side effects and his parents questioned the validity of the bipolar diagnosis. The controversy surrounding childhood bipolar disorder has led to a significant increase in diagnoses and medication use, raising concerns about the accuracy of these diagnoses and the safety of the medications used.

Depression drugs cannot cure people, but they can influence certain symptoms like emotional numbness and reduced self-care. However, these drugs can also cause sexual dysfunction even after discontinuation. Overall, these drugs are deemed terrible and should not be used. Psychiatry is unique in the healthcare field as its leaders consistently lie about the capabilities of their drugs. This situation is disheartening.

I'm feeling extremely unorganized, which has caused issues in my family and my self-employment. I have symptoms of ADD and depression, leading to a mixed picture of my mental health. It seems I might have low-grade bipolar disorder, which would require mood stabilizers. I'm more inclined towards ADD than ADHD. For treating depression, medications like Prozac, Zoloft, Paxil, or Lexapro are recommended. Starting with Lexapro in the morning and Trazodone at night could be beneficial. However, there's uncertainty about how effective the medication will be, as it often involves trial and error.